|
Market Closed -
Other stock markets
|
After hours 20:51:30 | |||
| 44.16 EUR | +3.47% |
|
44.04 | -0.29% |
| 07:38am | Bayer AG - FDA grants orphan drug designation to cell therapy OPCT-001 | RE |
| 05:17am | DAVOS: Top Executive Fears Widening Economic Gap with the US | DP |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 49.05B | |||||
| 966B | |||||
| 525B | |||||
| 382B | |||||
| 371B | |||||
| 278B |
- Stock Market
- Equities
- BAYN Stock
- Charts Bayer AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition